MODD
Modular Medical, Inc.
$4.86
+4.74%
$25.3M
No data for this timeframe.
Vol
Market Cap$25.3M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$615.5K
Inst. Activity0 buys / 1 sells
Reddit Sentiment50° Neutral
SEC Reports7
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. NV·CIK 0001074871·Prev Close $4.64
Recent Activity
May 14, 2026
Insider
Schmid Kevin sold 4,674 shares
Chief Operating Officer @ $0.00 ($0.00)
May 14, 2026
Insider
DiPerna Paul sold 11,218 shares
See Remarks @ $0.00 ($0.00)
Apr 23, 2026
SEC
Modular Medical (MODD) filed an S-3 shelf registration to raise up to $150 million, primarily through an $100 million at
S-3 — Impact 6/10
Apr 21, 2026
SEC
Modular Medical is raising $3.375 million through a registered direct offering of 750,000 shares at $4.50 per share, des
8-K — Impact 7/10
Apr 21, 2026
SEC
Modular Medical is raising $3.375 million through a public offering of 750,000 shares at $4.50 per share, despite having
424B5 — Impact 7/10
Mar 31, 2026
Insider
FRANK MORGAN C. sold 62 shares
Director @ $0.00 ($0.00)
Inst.
RENAISSANCE TECHNOLOGIES LLC — EXIT
0 shares ($0.00)
Inst.
RENAISSANCE TECHNOLOGIES LLC — NEW
46,900 shares ($32.8K)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 21, 2024 | Benchmark | REITERATE | Speculative Buy → Speculative Buy |
| Sep 19, 2023 | Oppenheimer | REITERATE | Outperform → Outperform |
| Jun 30, 2023 | Benchmark | REITERATE | Speculative Buy → Speculative Buy |
| May 19, 2023 | Oppenheimer | MAINTAIN | Outperform |
| Jan 30, 2023 | Benchmark | MAINTAIN | Speculative Buy |
Latest Reports
BEARISH
S-3
6/10
Modular Medical (MODD) filed an S-3 shelf registration to raise up to $150 million, primarily through an $100 million at
Apr 23, 2026
BEARISH
8-K
7/10
Modular Medical is raising $3.375 million through a registered direct offering of 750,000 shares at $4.50 per share, des
Apr 21, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $579.5K | — |
| MORGAN STANLEY | $19.3K | DOUBLED |
| BANK OF AMERICA CORP | $16.7K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 14, 2026 | Schmid Kevin | A | $0.00 |
| May 14, 2026 | DiPerna Paul | A | $0.00 |
| Mar 31, 2026 | FRANK MORGAN | A | $0.00 |
| Mar 31, 2026 | Vos Ellen | A | $0.00 |
| Mar 31, 2026 | Goldberg Jeff | A | $0.00 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
3 institutional holders with $615.5K total value (1,691,037 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, BANK. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,592,152 | $579.5K | 94.2% | — |
| 2 | MORGAN STANLEY | 53,000 | $19.3K | 3.1% | DOUBLED +165.9% |
| 3 | BANK OF AMERICA CORP /DE/ | 45,885 | $16.7K | 2.7% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 46,900 | 0 | -100.0% | $0.00 | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 46,900 | — | $32.8K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 1,600 | 200 | -87.5% | $140.00 | 2025-Q3 |
| CITADEL ADVISORS LLC | EXIT | 64,495 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 24,800 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | NEW | — | 64,495 | — | $88.4K | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 24,800 | — | $34.0K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 22,000 | 58,490 | +165.9% | $131.6K | 2024-Q3 |
9 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 14, 2026 | Schmid Kevin | Chief Operating Officer | A | 4,674 | $0.00 | $0.00 |
| May 14, 2026 | DiPerna Paul | See Remarks | A | 11,218 | $0.00 | $0.00 |
| Mar 31, 2026 | FRANK MORGAN C. | Director | A | 62 | $0.00 | $0.00 |
| Mar 31, 2026 | Vos Ellen O'Connor | Director | A | 250 | $0.00 | $0.00 |
| Mar 31, 2026 | Goldberg Jeff D | Director | A | 250 | $0.00 | $0.00 |
| Mar 31, 2026 | Sheibley Philip Brent | Director | A | 250 | $0.00 | $0.00 |
| Mar 31, 2026 | FELSHER STEVEN G | Director | A | 250 | $0.00 | $0.00 |
| Mar 31, 2026 | FELSHER STEVEN G | Director | A | 25 | $0.00 | $0.00 |
| Mar 31, 2026 | DeSisto Duane M | Director | A | 83 | $0.00 | $0.00 |
| Mar 31, 2026 | Volkart Carmen B | Director | A | 103 | $0.00 | $0.00 |
7 SEC filing reports analyzed. Sentiment: 0 bullish, 5 bearish, 0 mixed, 2 neutral. Avg impact: 6.0/10.
BEARISH
S-3
6/10
Modular Medical (MODD) filed an S-3 shelf registration to raise up to $150 million, primarily throug
Apr 23, 2026
BEARISH
8-K
7/10
Modular Medical is raising $3.375 million through a registered direct offering of 750,000 shares at
Apr 21, 2026
BEARISH
424B5
7/10
Modular Medical is raising $3.375 million through a public offering of 750,000 shares at $4.50 per s
Apr 21, 2026
NEUTRAL
8-K
3/10
Modular Medical, Inc. announced it has regained compliance with Nasdaq's minimum bid price requireme
Apr 16, 2026
BEARISH
424B4
7/10
Modular Medical (MODD) has priced a $12M best-efforts offering of 68.1M shares and warrants at $0.17
Mar 4, 2026
NEUTRAL
EFFECT
5/10
Modular Medical, Inc. (MODD) has announced the effectiveness of its S-1 registration statement, allo
Mar 4, 2026
BEARISH
S-1
7/10
Modular Medical, Inc. (MODD) is conducting a best-efforts IPO to raise up to $12 million through the
Feb 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Mar 2024): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 21, 2024 | Benchmark | REITERATE | Speculative Buy | Speculative Buy |
| Sep 19, 2023 | Oppenheimer | REITERATE | Outperform | Outperform |
| Jun 30, 2023 | Benchmark | REITERATE | Speculative Buy | Speculative Buy |
| May 19, 2023 | Oppenheimer | MAINTAIN | — | Outperform |
| Jan 30, 2023 | Benchmark | MAINTAIN | — | Speculative Buy |
| Apr 8, 2022 | Lake Street | INITIATE | — | Buy |
| Mar 25, 2022 | Benchmark | INITIATE | — | Speculative Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
4 mentions
0 bullish
0 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 20, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 20, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 15, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Apr 15, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.